Barbara Dalton - 02 Jun 2022 Form 4 Insider Report for IMARA Inc. (ELVN)

Role: Director
Signature: /s/ Michael P. Gray, Attorney-in-Fact
Issuer symbol: ELVN
Transactions as of: 02 Jun 2022
Transactions value $: $0
Form type: 4
Filing time: 03 Jun 2022, 20:20:32 UTC
Previous filing: 01 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ELVN	Common Stock						1.56M	02 Jun 2022	By entities affiliated with Pfizer Inc.	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELVN	Stock Options (Right to Buy)	Award	$0	+8.5K		$0.00	8.5K	02 Jun 2022	Common Stock	8.5K	$1.07	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is Managing General Partner, Pfizer Ventures (US) LLC. The reporting person disclaims beneficial ownership of the shares owned by the entities affiliated with Pfizer Ventures (US) LLC except to the extent of her pecuniary interest therein.
F2	The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant.